Captrust Financial Advisors Csl LTD Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	BUY	$87.94 - $101.67 $274,724 - $317,617	3,124 Added 22.78%	16,837 $1.55 Million
Q1 2022 May 16, 2022	BUY	$85.56 - $107.12 $9,411 - $11,783	110 Added 0.81%	13,713 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$97.41 - $116.74 $70,135 - $84,052	-720 Reduced 5.03%	13,603 $1.44 Million
Q3 2021 Nov 16, 2021	SELL	$101.72 - $114.56 $68,355 - $76,984	-672 Reduced 4.48%	14,323 $1.5 Million
Q2 2021 Aug 16, 2021	SELL	$100.62 - $116.66 $55,341 - $64,163	-550 Reduced 3.54%	14,995 $1.6 Million
Q1 2021 May 17, 2021	BUY	$95.11 - $111.11 $371,499 - $433,995	3,906 Added 33.56%	15,545 $1.58 Million
Q4 2020 Feb 16, 2021	BUY	$101.34 - $117.74 $284,866 - $330,967	2,811 Added 31.84%	11,639 $1.28 Million
Q3 2020 Nov 17, 2020	BUY	$95.79 - $111.95 $374,730 - $437,948	3,912 Added 79.58%	8,828 $920,000
Q2 2020 Aug 14, 2020	SELL	$90.75 - $104.91 $11,616 - $13,428	-128 Reduced 2.54%	4,916 $487,000
Q1 2020 May 15, 2020	BUY	$79.09 - $114.05 $398,929 - $575,268	5,044 New	5,044 $461,000

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $84.7B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.